Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies. Issue 2 (1st February 2020)

• Record Type: Journal Article
• Authors: Wang, Y.; Wang, L.F.; Zhang, L.L.; Sun, H.B.; Zhao, J.
• Is Part Of: SAR and QSAR in environmental research. Volume 31:Issue 2(2020)
• Page Start: 149
• Page End: 170
• Publication Date: 2020-02-01
• Subjects: Bromodomain-containing protein 9 -- binding free energy -- molecular dynamics -- principal component analysis -- MM-GBSA method; Structure-activity relationships (Biochemistry) -- Periodicals; QSAR (Biochemistry) -- Periodicals; 572.4
• DOI: 10.1080/1062936X.2019.1701075
• Languages: English
• ISSNs: 1062-936X

Abstract

ABSTRACT: Recently, bromodomain-containing protein 9 (BRD9) has been a prospective therapeutic target for anticancer drug design. Molecular dynamics (MD) simulations combined with molecular mechanics generalized Born surface area (MM-GBSA) method were adopted to explore binding modes of three inhibitors (5SW, 5U2, and 5U6) to BRD9 and identify the hot spot of the inhibitor-BRD9 binding. The results indicate that the inhibitor 5SW has the strongest binding ability to BRD9 among the current three inhibitors. Furthermore, the rank of the binding free energies predicted by MM-GBSA approach agrees with that determined by the experimental values. In addition, inhibitor-residue interactions were computed by using residue-based free-energy decomposition method and the results suggest that residue His42 produces the CH-H interactions, residues Asn100, Ile53 and Val49 produce the CH- π interactions with three inhibitors and Tyr106, Phe45 and Phe44 generate the π-π interactions with inhibitors. Notably, the residue Asn140 forms hydrogen bonding interactions with three inhibitors. This research is expected to provide useful molecular basis and dynamics information at atomic levels for the design of potent inhibitors inhibiting the activity of BRD9.